精优药业(00858.HK)授出合共7650万份购股权

Core Viewpoint - The company announced the grant of a total of 76.5 million share options to three grantees, all of whom are executive directors, under its share option scheme adopted on September 2, 2022 [1] Group 1 - The share options were granted to three individuals: Cheng Yong, Lou Yi, and Guo Yi, all of whom are executive directors of the company [1] - The announcement was made on December 19, 2025, indicating the company's ongoing commitment to incentivizing its executive team [1]